SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement

By afschroeder • August 29, 2025

Stein Gold L, Gottlieb AB, Armstrong AW, Alkousakis T, Bissonnette R, Langley RG, Krueger J, Papp K, Choi O, Rowland K, Chan D, Jeyarajah J, Park-Wyllie L, Gao LL, Gordon KB, Merola JF, Lebwohl MG, Strober B. SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement. Br J Dermatol. 2025 Aug 28:ljaf327. doi: 10.1093/bjd/ljaf327. Epub ahead of print. PMID: 40875818.

Tags: Dermatology, Publications

Correction for Hirsch et al., “Complete genome of Variovorax sp. EBFNA2, isolated from a surface-sterilized fava bean nodule”

Hirsch AM, Youseif SH, Humm E, Rubbi L, Del Vecchio G, Ha SM, Pellegrini M, Gunsalus RP. Correction for Hirsch et al., "Complete genome of Variovorax sp.[...]

Genomes of Syntrophomonas erecta GB4-38T and Syntrophomonas erecta subsp. sporosyntropha 5-3-ZT that degrade C4-8 short-chain fatty acids

Ha SM, Humm E, Wofford NQ, Sieber JR, Rubbi L, Del Vecchio G, Pellegrini M, McInerney MJ, Gunsalus RP. Genomes of Syntrophomonas erecta GB4-38T and Syntrophomonas erecta subsp. sporosyntropha 5-3-ZT that degrade C4-8[...]

Live imaging of vascular dynamics in mouse skin

Song I, Blumberg MA, Kam CY. Live imaging of vascular dynamics in mouse skin. J Invest Dermatol. 2026 Feb 12:S0022-202X(26)00024-2. doi: 10.1016/j.jid.2025.12.031. Epub ahead of[...]